The history of environmental injustice in the U.S. is well documented and has direct correlations with asthma and other respiratory conditions.
Read More
Bipartisan majorities support action on Biden campaign promises on Medicaid Home and Community Based Services, Supplemental Security Income.
Read More
In all eight states we find high levels of support for Medicaid expansion
Read More
Unfair health care pricing and aggressive medical debt collection practices have created financial devastation for millions of Americans.
Read More
Amid a significant spike in deaths among individuals experiencing homelessness in San Francisco, including a rise in overdose deaths, expanded harm reduction practices and substance use treatment during the COVID-19 pandemic have shown promising results in reducing death and harm from opioid use.
Read More
Asthma rates in the United States are intimately connected with environmental policy choices.
Read More
In 2018, more than 5,300 people in California died from a drug overdose, the most of any state in the country.
Read More
In the United States, drug overdoses have already claimed nearly a half million lives since 1999. Now authorities across the country are reporting a surge in overdose deaths as part of the pandemic fallout
Read More
Seven million Americans need insulin every day to control their blood sugar and avoid life-threatening medical events. This includes everyone with type 1 diabetes as well as many who have developed type 2 diabetes. The World Health Organization has designated insulin an “essential medicine”, which means that governments have a duty to make it affordable. In America, however, the cost of a vial of insulin has tripled over the past two decades. Put simply, because insulin is no longer affordable here, America is failing its duty.
Read More
The Affordable Drug Manufacturing Act, introduced into Congress by Senator Elizabeth Warren and Representative Jan Schakowsky would allow the government to manufacture generic versions of drugs in some circumstances. Because the legislation is likely to face strong industry push-back, we tested it in two environments: with and without a Democratic message in support. This is designed to simulate how the legislation would perform in an environment where it is massively outspent on television. We find that in both scenarios, voters overwhelmingly support the legislation.
Read More
Voters strongly prefer capping the costs of drugs at the lowest levels possible and invoking new fines and fees on pharmaceutical companies that raise their prices too high
Read More
Recently, Data for Progress and YouGov Blue conducted polling on voters’ attitudes toward Medicare for All, the current healthcare system, and other policies to reform healthcare in the United States. We included items asking voters how they felt about the current system, and about whether they felt the government should be more or less involved in the government.
Read More